Author Information
Dr. Jan I. Olofsson is a prominent researcher affiliated with the Global Medical Affairs, Established Pharmaceuticals Division at Abbott Product Operations AG in Allschwil, Switzerland. Additionally, he holds an academic position in the Division of Obstetrics and Gynecology at the Department of Women's and Children's Health, Karolinska Institutet in Stockholm, Sweden. His extensive background in gynecology, coupled with his dual roles in both clinical and pharmaceutical settings, underscores his significant contributions to women's health.Research Contributions
Dr. Jan I. Olofsson has made substantial contributions to the field of gynecology, particularly focusing on reproductive health, fertility preservation, and assisted reproductive technologies (ART). His research includes studies on the efficacy of dydrogesterone in managing chronic pelvic pain in endometriosis, the outcomes of uterus transplantation, and the impact of ART on DNA methylation at birth. Noteworthy among his works is the systematic review on oral alternatives to vaginal progesterone for IVF luteal phase support, and his investigation into the cumulative live birth rates in young women undergoing IVF. His contributions have provided valuable insights into the complexities of reproductive medicine and have influenced clinical practices and health policies.Aliases
J. Olofsson, J Olofsson, Jan I Olofsson, Jan I. Olofsson, J.i. Olofsson, J. Olofsson, J I Olofsson, J. I. Olofsson, Jan OlofssonPublication and Citation Metrics
| Metric |
Value |
| Total Papers |
65 |
| Total Citations |
1676 |
| H-index |
23 |
